| Status: | Phase 3 |
| Entry Type: | Unknown |
| Molecule Category: | UNKNOWN |
| UNII: | 4T6H12BN9U |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Burns | 3 | D002056 | ClinicalTrials |
| Pain | 3 | D010146 | ClinicalTrials |
| Psoriasis | 2 | D011565 | ClinicalTrials |
| Keratosis, Actinic | 2 | D055623 | ClinicalTrials |
| Staphylococcal Infections | 2 | D013203 | ClinicalTrials |
| Sunburn | 2 | D013471 | ClinicalTrials |
| Radiodermatitis | 1 | D011855 | ClinicalTrials |
| Wounds and Injuries | 1 | D014947 | ClinicalTrials |
| Tendinopathy | 1 | D052256 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL2108555 |
| FDA SRS | 4T6H12BN9U |
CONTENTS